OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
A Randomized Clinical Trial of a Fractional Low Dose of BNT162b2 Booster in Adults Following AZD1222
Rapisa Nantanee, Watsamon Jantarabenjakul, Peera Jaru-Ampornpan, et al.
Vaccines (2022) Vol. 10, Iss. 6, pp. 914-914
Open Access | Times Cited: 4
Rapisa Nantanee, Watsamon Jantarabenjakul, Peera Jaru-Ampornpan, et al.
Vaccines (2022) Vol. 10, Iss. 6, pp. 914-914
Open Access | Times Cited: 4
Showing 4 citing articles:
A systematic review and meta-analysis of the effectiveness and safety of COVID-19 vaccination in older adults
Kun Xu, Zihan Wang, Maorong Qin, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 42
Kun Xu, Zihan Wang, Maorong Qin, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 42
Comparing reactogenicity of COVID-19 vaccine boosters: a systematic review and meta-analysis
Alberto San Francisco Ramos, Carolina Liu-Sanchez, Tatiana Bovill Rose, et al.
Expert Review of Vaccines (2024) Vol. 23, Iss. 1, pp. 266-282
Open Access | Times Cited: 9
Alberto San Francisco Ramos, Carolina Liu-Sanchez, Tatiana Bovill Rose, et al.
Expert Review of Vaccines (2024) Vol. 23, Iss. 1, pp. 266-282
Open Access | Times Cited: 9
The immunologic outcomes and adverse events of COVID-19 vaccine booster dose in immunosuppressed people: A systematic review
SeyedAhmad SeyedAlinaghi, Mohsen Dashti, Arian Afzalian, et al.
Preventive Medicine Reports (2024) Vol. 44, pp. 102778-102778
Open Access | Times Cited: 1
SeyedAhmad SeyedAlinaghi, Mohsen Dashti, Arian Afzalian, et al.
Preventive Medicine Reports (2024) Vol. 44, pp. 102778-102778
Open Access | Times Cited: 1
Immunogenicity, safety, and reactogenicity of a half- versus full-dose BNT162b2 (Pfizer-BioNTech) booster following a two-dose ChAdOx1 nCoV-19, BBIBP-CorV, or Gam-COVID-Vac priming schedule in Mongolia: a randomised, controlled, non-inferiority trial
Tsetsegsaikhan Batmunkh, Kerryn A. Moore, Helen Thomson, et al.
The Lancet Regional Health - Western Pacific (2023) Vol. 42, pp. 100953-100953
Open Access | Times Cited: 3
Tsetsegsaikhan Batmunkh, Kerryn A. Moore, Helen Thomson, et al.
The Lancet Regional Health - Western Pacific (2023) Vol. 42, pp. 100953-100953
Open Access | Times Cited: 3
